Here’s Why Artisan Small Cap Fund Bets on Guardant Health (GH)

6 days ago 4

Soumya Eswaran

Tue, March 17, 2026 astatine 9:15 AM CDT 3 min read

Artisan Partners, an concern absorption company, released its fourth-quarter 2025 capitalist missive for “Artisan Small Cap Fund”. A transcript of the missive tin beryllium downloaded here. The Fund seeks to put successful companies that person franchise characteristics, with beardown net trajectories, and are trading astatine a discount to the estimated backstage marketplace value. Despite beardown results successful 2025, volatility was elevated, and sentiment shifted frequently, influenced by governmental developments successful the US, evolving commercialized argumentation rhetoric, changing expectations for monetary policy, and ongoing geopolitical tensions. Against this backdrop, the Fund posted beardown implicit returns successful the 4th quarter, outperforming some the Russell 2000® Growth Index and the Russell 2000® Index. The portfolio delivered beardown results successful the 4th crossed each segments. In contrast, for the afloat year, the Fund generated beardown results but trailed some the indexes. In Q4 2025, the marketplace enactment shifted backmost to companies with durable nett cycles. Moving to 2026, the steadfast continues to absorption connected its proven method of identifying nett cycles successful franchise companies astatine tenable valuations. Please reappraisal the Fund’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Artisan Small Cap Fund highlighted stocks similar Guardant Health, Inc. (NASDAQ:GH). Guardant Health, Inc. (NASDAQ:GH) is simply a precision oncology institution that specializes successful a liquid biopsy trial to observe crab from humor samples. On March 16, 2026, Guardant Health, Inc. (NASDAQ:GH) banal closed astatine $87.18 per share. One-month instrumentality of Guardant Health, Inc. (NASDAQ:GH) was -18.61%, and its shares gained 98.81% implicit the past 12 months. Guardant Health, Inc. (NASDAQ:GH) has a marketplace capitalization of $11.435 billion.

Artisan Small Cap Fund stated the pursuing regarding Guardant Health, Inc. (NASDAQ:GH) successful its 4th fourth 2025 capitalist letter:

"During the quarter, we initiated caller positions successful nLIGHT, Guardant Health, Inc. (NASDAQ:GH) and Cellebrite. Guardant Health is simply a person successful liquid biopsy diagnostics, utilizing a elemental humor gully to observe and show cancer. The institution holds an enviable market-leading presumption successful tumor-naïve minimal residual illness (MRD) testing, helping clinicians to place residual crab without anterior tumor tissue, and enactment therapy enactment and illness monitoring. Building connected this foundation, Guardant is expanding into tumor-informed MRD investigating to code a broader scope of objective needs and further fortify its presumption crossed the MRD landscape."

Read Entire Article